- Home
- ANL vs ANIX Comparison
ANL vs ANIX Comparison
Compare ANL & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- ANIX
- Stock Information
- Founded
- ANL 2004
- ANIX 1982
- Country
- ANL Cayman Islands
- ANIX United States
- Employees
- ANL N/A
- ANIX N/A
- Industry
- ANL
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- ANL
- ANIX Health Care
- Exchange
- ANL Nasdaq
- ANIX Nasdaq
- Market Cap
- ANL 73.8M
- ANIX 84.7M
- IPO Year
- ANL 2023
- ANIX 1987
- Fundamental
- Price
- ANL $1.82
- ANIX $2.57
- Analyst Decision
- ANL Strong Buy
- ANIX Strong Buy
- Analyst Count
- ANL 2
- ANIX 3
- Target Price
- ANL $9.00
- ANIX $9.00
- AVG Volume (30 Days)
- ANL 10.1K
- ANIX 42.2K
- Earning Date
- ANL 06-10-2025
- ANIX 06-10-2025
- Dividend Yield
- ANL N/A
- ANIX N/A
- EPS Growth
- ANL N/A
- ANIX N/A
- EPS
- ANL N/A
- ANIX N/A
- Revenue
- ANL N/A
- ANIX N/A
- Revenue This Year
- ANL N/A
- ANIX N/A
- Revenue Next Year
- ANL N/A
- ANIX N/A
- P/E Ratio
- ANL N/A
- ANIX N/A
- Revenue Growth
- ANL N/A
- ANIX N/A
- 52 Week Low
- ANL $1.10
- ANIX $2.07
- 52 Week High
- ANL $8.88
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- ANL 45.00
- ANIX 45.65
- Support Level
- ANL $1.71
- ANIX $2.53
- Resistance Level
- ANL $2.10
- ANIX $2.72
- Average True Range (ATR)
- ANL 0.09
- ANIX 0.15
- MACD
- ANL 0.01
- ANIX 0.00
- Stochastic Oscillator
- ANL 28.21
- ANIX 33.33
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.